|
|

Panorama Capital
invests in passionate entrepreneurs building leading
companies in life sciences and technology. Founded in 2005 as
the successor to the venture capital program of JPMorgan
Partners, we take a hands on, highly collaborative approach
to investing, bringing to bear the team's extensive operating
and investing experience to each portfolio company. The firm
is managed by a seasoned group of life sciences and technology
investors who collectively possess over 140 years of investment
and industry experience. In addition to our extensive investing
experience, we possesses broad experience as executives,
entrepreneurs, engineers, and physicians. This collective
experience gives Panorama Capital a powerful combination of
technical, entrepreneurial, operational, and transactional
expertise to help foster the development of our portfolio
companies.
|
|

Novus Ventures
was founded by Dan Tompkins in 1994 with the goal
of forming a venture capital team whose collective
talents and experience could help build great companies.
After raising their second fund in 2000 and merging
with Artemis Ventures in the summer of 2002, the Novus
Ventures team comprises seven seasoned investment
professionals managing a total of $150 million.
From the outset, the approach has been two-fold:
provide optimal funding for promising early-stage
companies; and contribute Novus resources and participation
to these ventures to help them grow and flourish in
the dynamic, challenging high-tech business world.
After investing in a portfolio company, Novus is
committed to a working process that melds seasoned
management expertise with the entrepreneurial vision
and drive of its portfolio companies.
The approach has proved successful. Headquartered
in Cupertino, California, Novus currently has $150
million under management, serves a roster of 26 active
portfolio companies, and offers the collective talent
of six principal working partners.
|
|
VantagePoint
Venture Partners is one of the leading venture
capital firms in the world. With an interest in companies
ranging from start-ups to pre-IPO, we're an active
multi-stage investor. Providing long-term capital,
we have more than $2.8 billion under management and
available for companies. Vantage Point focuses entirely
on technology and healthcare markets, organized around
five practice groups: Communications & Systems;
Software, Internet & Media; Semiconductors &
Components; Healthcare; and CleanTech.
Uniquely qualified to engage in ambitious projects,
VantagePoint has served as the sole or co-lead investor
in more than 150 of its portfolio companies. This
level of leadership is second-nature for the Firm's
Managing Directors, who have an average of 18 years
of venture capital and high-level technology experience.
As a full-service team with deep resources, we have
helped more than 600 companies complete IPOs or M&A
transactions - a building process that takes place
side-by-side with the portfolio companies' management
teams
Founded in 1996, Vantage Point has offices in Silicon
Valley, New York, and Montreal. |
|
Since its founding in 1972, KPCB has backed entrepreneurs in over 475 ventures,
including AOL, Align Technology, Amazon.com, Citrix, Compaq Computer, Electronic
Arts, Genentech, Genomic Health, Google, IDEC Pharmaceuticals, Intuit, Juniper
Networks, Netscape, Lotus, LSI Logic, Sun Microsystems, Symantec, VeriSign and
Xilinx. More than 150 of the firm's portfolio companies have gone public. Many other
ventures have achieved success through mergers and acquisitions. Additional
information can be found at www.kpcb.com/greentech.
|
|
|
|
|